Uri Weinberg Novo Cure LTD (NVCR) insider trading activity

Uri Weinberg is Chief Innovation Officer of NovoCure Ltd. Currently has a direct ownership of 221,218 shares of NVCR, which is worth approximately $4.31 Million. The most recent transaction as insider was on Mar 04, 2025, when has been sold 54,975 shares (Ordinary Shares) at a price of $18.19 per share, resulting in proceeds of $999,995. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 221K

29.26% 3M change

29.26% 12M change

Total Value Held $4.31 Million

Uri Weinberg Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 04 2025	BUY Grant, award, or other acquisition	$999,995 $18.19 p/Share	54,975 Added 19.9%	221,218 Ordinary Shares
Mar 03 2025	SELL Open market or private sale	$5,070 $18.92 p/Share	268 Reduced 0.16%	166,243 Ordinary Shares
Feb 28 2025	SELL Open market or private sale	$86,016 $18.55 p/Share	4,637 Reduced 2.71%	166,511 Ordinary Shares
Feb 27 2024	BUY Grant, award, or other acquisition	$1,333,323 $16.3 p/Share	81,799 Added 32.34%	171,148 Ordinary Shares
Jun 30 2023	BUY Grant, award, or other acquisition	$10,760 $35.28 p/Share	305 Added 0.34%	89,349 Ordinary Shares
Mar 03 2023	BUY Grant, award, or other acquisition	-	32,766 Added 26.9%	89,044 Ordinary Shares
Feb 28 2023	BUY Grant, award, or other acquisition	-	12,992 Added 18.76%	56,278 Ordinary Shares
Jan 05 2023	SELL Open market or private sale	$952,731 $117.0 p/Share	8,143 Reduced 15.83%	43,286 Ordinary Shares
Jan 05 2023	BUY Exercise of conversion of derivative security	$91,539 $47.04 p/Share	1,946 Added 3.82%	49,050 Ordinary Shares
Jul 05 2022	BUY Grant, award, or other acquisition	$16,601 $59.08 p/Share	281 Added 0.56%	49,483 Ordinary Shares
Mar 03 2022	BUY Grant, award, or other acquisition	-	17,371 Added 26.1%	49,186 Ordinary Shares
Jan 06 2022	BUY Grant, award, or other acquisition	$2,234 $63.82 p/Share	35 Added 0.11%	31,815 Ordinary Shares
Jul 06 2021	BUY Grant, award, or other acquisition	$15,495 $137.12 p/Share	113 Added 0.35%	31,780 Ordinary Shares
May 10 2021	SELL Open market or private sale	$1,071,522 $189.65 p/Share	5,650 Reduced 15.14%	31,667 Ordinary Shares
May 10 2021	BUY Exercise of conversion of derivative security	$182,916 $47.56 p/Share	3,846 Added 9.34%	37,317 Ordinary Shares
Mar 23 2021	SELL Open market or private sale	$544,880 $140.0 p/Share	3,892 Reduced 9.68%	36,306 Ordinary Shares
Mar 23 2021	BUY Exercise of conversion of derivative security	$183,080 $47.04 p/Share	3,892 Added 8.83%	40,198 Ordinary Shares
Mar 02 2021	BUY Grant, award, or other acquisition	-	8,709 Added 19.35%	36,306 Restricted Share Units
Feb 22 2021	SELL Open market or private sale	$1,140,750 $175.5 p/Share	6,500 Reduced 19.06%	27,597 Ordinary Shares
Feb 22 2021	BUY Exercise of conversion of derivative security	$46,475 $7.15 p/Share	6,500 Added 16.01%	34,097 Ordinary Shares

Uri Weinberg

Chief Innovation Officer

Malvern, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NVCR shares.

Notify only if

Value

Insider Trading

Get notified when an Novo Cure LTD insider buys or sells NVCR shares.

Notify only if

Operation

Value

Type

News

Receive news related to NovoCure Ltd

Track Activities on NVCR

Account